Clinical characteristics and treatment outcomes in six cases of malignant tenosynovial giant cell tumor: initial experience of molecularly targeted therapy

Table 1 Patients’ demographics

Case	Sex	Primary site	Age (Y)		de novo or metachronous (lag time)	Surgery	Adjuvant radiotherapy	Local recurrence	Additional surgery	Lymph node involvement	Pulmonary metastasis
Case	Sex	Primary site	At initial diagnosis	At diagnosis with mTGCT	de novo or metachronous (lag time)	Surgery	Adjuvant radiotherapy	Local recurrence	Additional surgery	Lymph node involvement	Pulmonary metastasis
1	Female	Knee joint	12	33	metachronous (21 years)	Amputation	No	Yes	Hemipelvectomy	Yes	Yes
2	Male	Thigh	53	53	de novo	Resection	Yes	Yes	No	Yes	Yes
3	Female	Knee	55	55	metachronous (3 months)	Amputation	No	Yes	No	Yes	Yes
4	Female	Hip	46	46	de novo	Not indicated	Yes	.	.	N.A.	Yes
5	Male	Thigh	44	47	metachronous (3 years)	Resection	No	Yes	No	No	Yes
6	Male	Knee joint	55	55	metachronous (3 months)	Amputation	No	No	.	Yes	Yes

ISSN: 1471-2407